NeoPhore Limited, a cancer immuno-oncology company, announced yesterday that it has named Dr John Haurum as its new non-executive director with immediate effect.

Dr Haurum was earlier chief executive officer of F-star. Before F-star, he was VP Research at ImClone Systems, prior to this he was the CSO and Co-founder of Symphogen. He is currently executive chairman of the board at Synklino.

Robert James, chairman of NeoPhore, said, 'I would like to welcome John to the Neophore board. John has an excellent track record of building and growing companies in the biotech industry and his expertise and scientific understanding of the IO space will be invaluable as we maximise the potential of our platform.'